Clinical Trials Browser

Locked-In Syndrome, Amyotrophic Lateral Sclerosis, Muscular Dystrophies, Parkinson Disease, Spinal Cord Injuries, Multiple System Atrophy, Brain Stem Infarctions, Parkinsonian Disorders

NCT03516994 2024-05-16

EQUALACP

Phase NA Completed

790 enrolled

Genitourinary

Amyotrophic Lateral Sclerosis, Heart Failure, Kidney Failure, Chronic, Neoplasm Metastasis, Parkinson Disease, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, Diabetes Complications, End Stage Liver Disease

NCT03042416 2022-01-10

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

Phase 3 Completed

400 enrolled

CNSEndocrineNET

Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Congenital Hyperinsulinism

NCT02819011 2020-02-27

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Phase 2 Completed

44 enrolled 16 charts

Frailty, Arthritis, Diabetes Mellitus, Neoplasms, Parkinson Disease, Peripheral Arterial Disease

NCT01691924 2016-03-08

Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers

Phase 1 Completed

56 enrolled

Neoplasms, Parkinson Disease

NCT02111330 2016-03-08

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers

Phase 1 Completed

16 enrolled

Neoplasms, Parkinson Disease

NCT02015806 2016-01-11

REMIND

Phase NA Completed

53,480 enrolled

BreastGenitourinary

Mental Disorders, Breast Neoplasms, Cardiovascular Diseases, Depression, Diabetes Mellitus, Epilepsy, Parkinson Disease, Prostatic Hyperplasia, Medication Adherence

NCT01698450 2014-10-09

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

Phase 1 Completed

10 enrolled

Dystonia, Movement Disorders, Neuralgia, Parkinson Disease, Essential Tremor

Clinical Trials

BCI-FIT

EQUALACP

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers

REMIND

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders